Medicare Enrolled
Dr. Mark Hoffman, MD
Hematology & Oncology · New Hyde Park, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hoffman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hoffman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hoffman
Dr. Mark Hoffman is a hematology & oncology specialist in New Hyde Park, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hoffman performed 26,828 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Hoffman received a total of $1,467 from 10 pharmaceutical and/or device companies across 42 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hoffman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 17% volume in NY
$1,467 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗26,828
Medicare services
Top 17% in NY for hematology & oncology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
20,010 | $0 | $5 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
1,300 | $6 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
921 | $8 | $32 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
707 | $8 | $35 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
577 | $10 | $44 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
573 | $107 | $413 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
493 | $0 | $5 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
279 | $79 | $286 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
268 | $6 | $30 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
186 | $6 | $25 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
157 | $13 | $65 |
| New patient office visit, complex (60-74 min) | 120 | $190 | $750 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
114 | $1 | $5 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
113 | $7 | $40 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
108 | $157 | $568 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
105 | $12 | $105 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
103 | $15 | $80 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
102 | $13 | $64 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
95 | $60 | $335 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
88 | $123 | $685 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
54 | $27 | $150 |
| Iron level test | 53 | $6 | $30 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
52 | $9 | $50 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
48 | $15 | $70 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
39 | $4 | $20 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
35 | $1 | $5 |
| Haptoglobin level test A blood test that measures the amount of haptoglobin, a protein in the serum. It helps evaluate red blood cell breakdown. |
33 | $12 | $47 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
29 | $8 | $30 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $50 | $194 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
20 | $3 | $10 |
| High-sensitivity C-reactive protein test A blood test that measures high-sensitivity C-reactive protein to detect infection or inflammation. |
13 | $13 | $50 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
12 | $15 | $76 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
75.9% high complexity
8.0% medium
16.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,467
Total received (2018-2024)
Avg $245/year across 6 years
Bottom 48% in NY for hematology & oncology
10
Companies
42
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$972
2023
$204
2022
$97
2021
$69
2019
$36
2018
$89
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$885
Gilead Sciences, Inc.
$27
Myriad Genetic Laboratories, Inc.
$25
Stemline Therapeutics Inc.
$18
Alexion Pharmaceuticals, Inc.
$16
Top 3 companies account for 96.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,176
TESARO, Inc.
$70
Celgene Corporation
$51
Gilead Sciences, Inc.
$39
Medtronic USA, Inc.
$36
Myriad Genetic Laboratories, Inc.
$25
Merck Sharp & Dohme Corporation
$19
Stemline Therapeutics Inc.
$18
E.R. Squibb & Sons, L.L.C.
$17
Alexion Pharmaceuticals, Inc.
$16
Top 3 companies account for 88.4% of all-time payments
Associated products mentioned in payments ›
INTELLIS · KEYTRUDA · KISQALI · MYRISK · Orserdu · PIQRAY · Pomalyst · REBLOZYL · ULTOMIRIS · ZEJULA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
670
County median income
$143,408
Nearest hospital to ZIP centroid (approximate)
LONG ISLAND JEWISH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hoffman is a mixed practice specialist, with above-average Medicare volume (top 17% in NY), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hoffman experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Hoffman performed 20,010 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Hoffman receive payments from pharmaceutical companies?
Yes. Dr. Hoffman received a total of $1,467 from 10 companies across 42 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hoffman's costs compare to other hematology & oncology specialists in New Hyde Park?
Dr. Hoffman's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hoffman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in New Hyde Park
Browse hematology & oncology specialists in New Hyde Park ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
TESARO, Inc. Payments to Doctors
See all physicians who received payments from TESARO, Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology